Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V T Devita

Showing results (41-50 of 268) with videos related to

Pageof 27
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 1, 1979
Human models of human diseases; breast cancer and the lymphomasV T DeVita
Annals of the New York Academy of Sciences|November 30, 1993
Dose intensity. The neglected variable in clinical trialsA Surbone, V T DeVita
American Industrial Hygiene Association Journal|May 1, 1980
IARC monographs on the evaluation of carcinogenic risk of chemicals to humansJ Higginson, V T DeVita
Annals of Internal Medicine|October 1, 1973
Editorial: Infection and cancer: old friendsV T DeVita, C Young
Hospital Practice (Office Ed.)|February 15, 1987
The emergence of biologicals as cancer treatment: the good news and the badV T DeVita, M Roper
Cancer Journal (Sudbury, Mass.)|August 16, 2001
National Oncology Forum: perspectives for the year 2000V T DeVita, E W Bleickardt
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
LymphomasD L Longo, V T DeVita
JAMA|June 19, 1996
OncologyV T DeVita, A B Deisseroth
Connecticut Medicine|September 1, 1980
Of mice and men: what animal tests of carcinogens mean to usV T Devita, H P Kennedy
American Pharmacy|April 1, 1980
Cancer, the curable diseasesV T DeVita, L M Kershner
Pageof 27

Showing results (41-50 of 268) with videos related to

Sort By:
Pageof 27
International Journal of Radiation Oncology, Biology, Physics|October 1, 1979
Human models of human diseases; breast cancer and the lymphomasV T DeVita
Annals of the New York Academy of Sciences|November 30, 1993
Dose intensity. The neglected variable in clinical trialsA Surbone, V T DeVita
American Industrial Hygiene Association Journal|May 1, 1980
IARC monographs on the evaluation of carcinogenic risk of chemicals to humansJ Higginson, V T DeVita
Annals of Internal Medicine|October 1, 1973
Editorial: Infection and cancer: old friendsV T DeVita, C Young
Hospital Practice (Office Ed.)|February 15, 1987
The emergence of biologicals as cancer treatment: the good news and the badV T DeVita, M Roper
Cancer Journal (Sudbury, Mass.)|August 16, 2001
National Oncology Forum: perspectives for the year 2000V T DeVita, E W Bleickardt
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1990
LymphomasD L Longo, V T DeVita
JAMA|June 19, 1996
OncologyV T DeVita, A B Deisseroth
Connecticut Medicine|September 1, 1980
Of mice and men: what animal tests of carcinogens mean to usV T Devita, H P Kennedy
American Pharmacy|April 1, 1980
Cancer, the curable diseasesV T DeVita, L M Kershner
Pageof 27